Middle-aged men with upper-normal blood pressure at risk for AF

January 17, 2012

Middle-aged men at the upper end of normal blood pressure had an elevated risk for atrial fibrillation later in life, according to new research in Hypertension: Journal of the American Heart Association.

Atrial fibrillation (AF) is a common in which can lead to stroke and other heart-related complications; it affects over 2.7 million Americans. While hypertension is a risk factor for AF, the of upper-normal are not yet fully understood.

"Women with blood pressure on the upper end of the normal range have been shown to be at increased risk for AF," said Irene Grundvold, M.D., lead author of the study and consultant cardiologist in the Cardiology Department at Oslo University Hospital in Ullevaal, Norway. "We set out to determine if the same was true for men who are not yet considered hypertensive."

For 35 years, researchers followed 40- to 59-year-old healthy Norwegian men from a database of 2,014. They recorded the men's blood pressure at the start of the study and tracked health events such as AF. They conducted a follow-up survey an average of seven years after the initial survey, in which 1,758 men participated. Beyond seven years, only men who were considered healthy were included in analysis, which reduced the number of participants to 1,423.

U.S. guidelines define as systolic pressure (top number) at 140 millimeters of mercury (mm Hg) or higher and diastolic pressure (bottom number) at 90 mm Hg or higher. They define pre-hypertension as systolic pressures from 120 to 139 mm Hg and diastolic pressures from 80 to 89 mm Hg.

In the study, while upper-normal systolic blood pressure was 128-138 mm Hg, the authors acknowledge that the range differs from current European blood pressure guidelines.

During the study's follow-up, 270 men, or 13 percent, developed AF. Major findings from the study include:

• Men with systolic blood pressure of 140 mm Hg or higher at the start of the study had a 60 percent increased risk of developing AF, compared to men with normal systolic blood pressure.

• Men with of 128 to 138 mm Hg (upper normal) had a 50 percent increased risk of developing AF during follow-up, compared with men with systolic pressures below 128 mm Hg (normal).

• Men with diastolic blood pressure of 80 mm Hg or higher at the start of the study had a 79 percent increased risk of subsequent AF, compared with men with diastolic blood pressure below 80 mm Hg (normal).

• On average, developed 20 years after baseline.

"Our results indicate that men with upper-normal blood pressure appear to have a higher risk for AF than men with lower blood pressure," Grundvold said.

In an accompanying editorial, Paolo Verdecchia, M.D., notes that global preventive strategies are urgently needed to reduce the burden of AF. Because the risk of AF increases among men and women in the pre-hypertension range, it's important that further studies clarify the relationship between blood pressure control strategies and the risk of AF, wrote Verdecchia who is chief of the division of Medicine at the Hospital of Assisi in Assisi, Italy.

Results from the study can't be generalized to men of different ethnicities, ages, men with health conditions or to women because researchers only looked at healthy, middle-aged Norwegian .

Explore further: Blood pressure medicines reduce stroke risk in people with prehypertension

Related Stories

Recommended for you

Artificial heart design features porous plastic foam

October 2, 2015

Artificial hearts with multiple moving parts increase the chance of failure; scientists have worked up a device which is a single piece. No less interesting is the material they used; the team is taking a page out of soft ...

What powers the pumping heart?

September 25, 2015

Researchers at the Ted Rogers Centre for Heart Research have uncovered a treasure trove of proteins, which hold answers about how our heart pumps—a phenomenon known as contractility.

Sticky gel helps stem cells heal rat hearts

September 24, 2015

A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.